Bumbea, V.
19  results:
Search for persons X
?
 
?
3

PB2259: MONOCYTE'S INVOLVEMENT IN INFLAMMATORY RESPONSE IN ..:

Bumbea, V ; Bumbea, H ; Ardelean, L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431458/.  , 2022
 
?
4

PB2259: MONOCYTE'S INVOLVEMENT IN INFLAMMATORY RESPONSE IN ..:

V. Bumbea ; H. Bumbea ; L. Ardelean...
http://journals.lww.com/10.1097/01.HS9.0000851864.54887.0a.  , 2022
 
?
6

Mast Cell Diseases in Practice and Research: Issues and Per..:

Jennings, Susan V. ; Finnerty, Celeste C. ; Hobart, Jessica S....
The Journal of Allergy and Clinical Immunology: In Practice.  10 (2022)  8 - p. 2039-2051 , 2022
 
?
 
?
11

P1602: THE ASSESSMENT OF LYMPHOPENIA AS RISK FACTOR FOR UNF..:

Popov, V ; Iliescu, L ; Grigorie, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430569/.  , 2022
 
?
12

Mast Cell Diseases in Practice and Research:Issues and Pers..:

Jennings, Susan V ; Finnerty, Celeste C ; Hobart, Jessica S...
https://research.rug.nl/en/publications/adeb3246-5252-4406-99ad-f5f6da35f8b2.  , 2022
 
?
14

Mast cell diseases in practice and research : issues and pe..:

Jennings, Susan V ; Finnerty, Celeste C ; Hobart, Jessica S...
Journal of Allergy and Clinical Immunology: In Practice--2213-2198--2213-2201 Vol. 10 Issue. 8 No. pp: 2039-2051.  , 2022
 
?
15

Frontline treatment with the combination obinutuzumab ± chl..:

Herishanu Y ; Shaulov A ; Fineman R...
info:eu-repo/semantics/altIdentifier/pmid/32096887.  , 2020
 
1-15